Katie Eyes, MSW, reflects on 25 years of the BCBSNC Foundation and, over her 18 years with the organization, its shift toward ...

MFN pegs US net prices to the second-lowest net price in an eight-country basket, using rebate-inclusive definitions to limit list-price inflation and rebate-based circumvention. Prospective MFN for ...

Rising rates appear concentrated in hormone receptor–positive disease, aligning with later age at first birth, fewer ...

Swedish registry follow-up of >5.3 million pre-pandemic and >5.5 million pandemic adults linked death of a partner, child, ...

Tapia, MD, PhD, discusses the results of the ADAPT OCULUS trial, which found promising results for treating patients with ...

Healthcare data’s high fraud utility and broad clinical dependencies make ransomware uniquely harmful, coupling identity ...

Shara Bialo, MD, emphasizes the crucial role of school nurses in early detection of type 1 diabetes. In recognition of ...

FDA regulatory momentum includes priority review and breakthrough therapy designation for a potential first-in-class CHB ...

The US national crisis hotline, 988, was contacted over 18 million times since its launch in July of 2022; however, despite ...

Evidence suggests that adoption of oncology biosimilars in Medicare value-based payment models has produced substantial cost ...

Shared decision-making and quality of life are increasingly shaping metastatic breast cancer care amid persistent social barriers, notes Hayley Knollman, MD.

Federal directives deploy priority review vouchers, earlier DEA rescheduling, and ARPA-H matching funds to compress ...